Clinical Trial Update: INSTANT: INtegrilin Plus STenting to Avoid Myocardial Necrosis Trial [Phase 3]

View source ↗

Summary

This INSTANT Phase 3 trial update notes completion of the study evaluating Integrilin (eptifibatide) with stenting to prevent myocardial necrosis in cardiovascu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Artery Disease
• Myocardial Infarction

Drugs mentioned

• Integrilin (Eptifibatide)

Snippet

Sponsor: Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS | Conditions: Cardiovascular Disease | Phase 3 | Status: COMPLETED